XIENCE XPEDITION 1074300-15Recalls & reported problems
Abbott Vascular Inc. · XIENCE Xpedition Everolimus Eluting Coronary Stent System 3.00 mm x 15 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE XPEDITION (41)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648162336), received between Aug 9, 2017 and Oct 2, 2018 — classified as 3 injuries.
The most frequently reported specific device problem is “Failure to Advance” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Failure to Advance2
- Adverse Event Without Identified Device or Use Problem1
- Device Dislodged or Dislocated1
- Difficult to Remove1
Patient problems
- Angina1
- Embolism1
- Non specific EKG/ECG Changes1
- Thrombosis1
- Vessel Or Plaque, Device Embedded In1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryOct 2, 2018Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated; Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A HEAVILY CALCIFIED LESION IN THE MID LEFT MAIN ARTERY. A 3.0X15MM XIENCE XPEDITION STENT DELIVERY SYSTEM FAILED TO CROSS DUE TO THE ANATOMY; HOWEVER, WHEN AN ATTEMPT TO REMOVE THE SDS WAS MADE IT WAS NOTED THAT THE STENT WAS CAUGHT WITH THE ANATOMY AND THE STENT DISLODGED. THE PHYSICIAN STATED THAT THIS WAS DUE TO THE TIGHT AND CALCIFIED LESION, NOT DUE TO A DEVICE MALFUNCTION. AN UNSPECIFIED BALLOON CATHETER WAS ADVANCED TO COMPRESS THE STENT AGAINST THE ARTERY AND A SECOND UNSPECIFIED STENT WAS DEPLOYED OVER THE CRUSHED STENT. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH AN UNSPECIFIED DEVICE. THERE WERE NO ADVERSE PATIENT SEQUELA AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Vessel Or Plaque, Device Embedded In
MAUDE report 7927741 ↗InjurySep 29, 2017Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2014, THE PATIENT PRESENTED WITH UNSTABLE ANGINA AND A 3.0 X 15 MM XIENCE XPEDITION STENT WAS DEPLOYED IN THE CORONARY ARTERY. ON (B)(6) 2017, THE PATIENT WAS MOVED TO THE HOSPITAL BY EMERGENCY VISIT AND HOSPITALIZED WITH CHEST PAIN. THROMBUS (IN-STENT) WAS CONFIRMED BY ANGIOGRAPHY. A THROMBUS SUCTION CATHETER AND EXCIMER LASER WERE USED TO TREAT THE THROMBUS. ON (B)(6) 2017, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Thrombosis
MAUDE report 6904086 ↗InjuryAug 9, 2017Failure to Advance
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MODERATELY TORTUOUS, ECCENTRIC AND MILDLY CALCIFIED DE NOVO MID RIGHT CORONARY ARTERY THAT WAS 99% STENOSED. THE PATIENT PRESENTED WITH SEVERE CORONARY ARTERY DISEASE IN 3 VESSELS, AN INFERIOR SEGMENT ELEVATED MYOCARDIAL INFARCTION (STEMI), AND THROMBUS WITH A TIMI I FLOW. DURING THE ADVANCEMENT OF A 3.0 X 15 MM XIENCE XPEDITION STENT, EMBOLIZATION OF THROMBUS OCCURRED WITH ST ELEVATION. THEREFORE, THE STENT FAILED TO CROSS THE LESION AND IT WAS REMOVED AND REPLACED WITH A 3.0 X 23 XIENCE XPEDITION STENT TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT SEQUELA REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Embolism; Non specific EKG/ECG Changes
MAUDE report 6779012 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page